Brief: Crossject: End-Dec Cash Of EUR 8 mln
21/03/2023 07:35
March 21 (Reuters) - Crossject SA 74C.F :
* FY OPERATING EXPENSES AT EUR 23.0 MILLION VERSUS EUR 18.6
MILLION YEAR AGO
* FY OPERATING INCOME EUR 9.7 MILLION VERSUS EUR 6.8 MILLION
YEAR
AGO
* FY NET LOSS EUR 11.2MLN VERSUS EUR 10.7 MILLION YEAR AGO
* AS OF 31 DECEMBER 2022, CROSSJECT HAD CASH OF EUR 8
MILLION
Source text for Eikon: ID:nGNE1zDnxk
Further company coverage: 74C.F
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Crossject SA
See all newsBrief: Crossject Says Expects To File For EUA Early Next Year For Epilepsy Rescue Therapy Zepizure
Brief: Crossject Signs A Geographic Extension Of Zepizure Commercialization Agreement In Europe
Brief: Crossject FY Operating Income Up At EUR 12.82 Mln
Brief: Crossject Announces Contract Of Up To $155 Mln With BARDA
Brief: Crossject Engages Syneos Health For U.S. Commercial Launch Of Zepizure